Global Intravenous IV fluid bags Market

Global Intravenous IV Fluid Bags Market Size, Share, Growth Analysis, By Fluid Type(Total Parenteral Nutrients, Peripheral Parenteral Nutrition), By Nutrients(Carbohydrates, Vitamins) - Industry Forecast 2024-2031


Report ID: SQSG35A2033 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 65 | Figures: 75

Global Intravenous IV Fluid Bags Market Regional Insights

In 2021, North America held the largest share of the global market and generated more than 40.7% of the total revenue. This is owing to increase in the number of elderly people, which raises the demand for intravenous solutions, the prevalence of chronic diseases, and the industry's expansion in response to the flu and coronavirus pandemic's increased demand. During the projection period, the Asia-Pacific region is anticipated to have the quickest CAGR.

The high rate of growth in this area can be attributed to the fact that both public and private organizations spend a lot of money on research, as well as to advancements in technology and an increase in partnerships between different groups of stakeholders, such as universities and the medical community. Additional important factors that are anticipated to fuel market growth in the Asia Pacific region include the rising prevalence of chronic diseases brought on by bad eating habits and the rising desire for cost-effective treatments.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Intravenous IV Fluid Bags Market size was valued at USD 6 billion in 2019 and is poised to grow from USD 6.21 billion in 2023 to USD 9.2 billion by 2031, growing at a CAGR of 4.9% in the forecast period (2024-2031).

The top players are concentrated on expansion tactics such as teaming up with successful individuals and national initiatives or programmes that advertise their goods. Key development strategies, market share analysis, and market ranking analysis of the players globally are also included in the competitive landscape section. 'Baxter International Inc.', 'B. Braun Melsungen AG', 'Hospira Inc. (Pfizer Inc.)', 'Sippex IV Infusion Bags', 'Otsuka Pharmaceutical Co. Ltd.', 'Amcor Limited', 'Wipak Group', 'KRaton Corporation', 'ICU Medical Inc.', 'Renolit SE', 'West Pharmaceutical Services Inc.', 'Nipro Corporation', 'PolyCine GmbH', 'Terumo Corporation', 'Grifols S.A.', 'Fresenius SE & Co. KGaA', 'Angiplast Private Limited', 'Maco Pharma', 'Technoflex', 'Polycine GmbH'

The aging population is a factor in the expansion of the intravenous fluid bags industry globally. Aging causes a variety of illnesses, which in turn increases the need for effective drug administration techniques. Drugs administered intravenously are preferred to those administered orally because the former produce outcomes more quickly and accurately. Increased consumer knowledge is expected to result in a preference for intravenous fluid administration, which will support market expansion over the course of the projected period.

One of the main factors boosting the growth of the medical fluid bags market globally is the increase in the prevalence of various chronic diseases like diabetes, cancer, cardiovascular diseases, kidney, and liver infections. Additionally, the industry will grow as gastrointestinal diseases become more common, especially among the elderly population. The use of PVC-based medical fluid bags can have negative health effects on patients, and improper disposal can have a negative environmental impact. These issues could slow the market's expansion. On the other hand, the use of intravenous fluid bags has increased significantly due to the global expansion of hospitals and the healthcare industry.

In 2021, North America held the largest share of the global market and generated more than 40.7% of the total revenue. This is owing to increase in the number of elderly people, which raises the demand for intravenous solutions, the prevalence of chronic diseases, and the industry's expansion in response to the flu and coronavirus pandemic's increased demand. During the projection period, the Asia-Pacific region is anticipated to have the quickest CAGR.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Intravenous IV fluid bags Market

Product ID: SQSG35A2033

$5,300
BUY NOW GET FREE SAMPLE